Hello everyone and Happy New Year...my question relates to thinking that a valuation may potentially be done otherwise could they issue GNBT shares to employees? Or maybe it’s the reason why there is no talk of NGIO stock as it may still not be done. Anyone know how long it usually takes to valuate a business while doing a roadshow and FDA regulatory work? Perhaps the employee share thing is unrelated, but I trust that there is forward momentum on things. It was nice to see the PR last week and infer so much real progress.

I would think that if they started in early November that they may be getting very close to being finished with valuation & road show.

Hopefully we get strong news soon!